What should I Know Regarding Pregnancy, Nursing and Administering Sorafenib Tablet to Children or the Elderly?

If you are PREGNANT

  • Not Recommended: USE CONTRACEPTION DURING TREATMENT AND FOR 6 MONTHS AFTER; MAY CAUSE FETAL HARM

If you are NURSING

  • Absolute Contraindication: INSUFFICIENT HUMAN DATA AVAIL; POTENTIAL FOR SERIOUS ADVERSE EFFECTS

If you are an adult over 60

Giving Sorafenib Tablet to a child under 12

  • management or monitoring precaution: Not studied in pediatrics. No safety and efficacy. Potential risk of bone and bone marrow abnormalities.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.